These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27634031)

  • 1. Prognostic Significance of Nonsustained Ventricular Tachycardia Episodes Occurring Early After Implantable Cardioverter-Defibrillator Implantation Among Patients With Left Ventricular Dysfunction.
    Jiménez-Candil J; Hernández J; Perdiguero P; Martín A; Moríñigo J; Bravo L; Durán O; Sánchez PL
    Am J Cardiol; 2016 Nov; 118(10):1503-1510. PubMed ID: 27634031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies.
    Jiménez-Candil J; Duran O; Oterino A; Pérez J; Castro JC; Hernández J; Moríñigo J; García MS; Sánchez PL
    BMC Cardiovasc Disord; 2021 May; 21(1):268. PubMed ID: 34058991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
    Wang W; Lian Z; Rowin EJ; Maron BJ; Maron MS; Link MS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.
    Francia P; Santini D; Musumeci B; Semprini L; Adduci C; Pagannone E; Proietti G; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1180-7. PubMed ID: 25066044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular function improvement after prophylactic implantable cardioverter-defibrillator implantation in patients with non-ischaemic dilated cardiomyopathy.
    Grimm W; Timmesfeld N; Efimova E
    Europace; 2013 Nov; 15(11):1594-600. PubMed ID: 23639855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second coupling interval of nonsustained ventricular tachycardia to distinguish malignant from benign outflow tract ventricular tachycardias.
    Kim YR; Nam GB; Kwon CH; Lee WS; Kim YG; Hwang KW; Kim J; Choi KJ; Kim YH
    Heart Rhythm; 2014 Dec; 11(12):2222-30. PubMed ID: 25111325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of ventricular tachyarrhythmias in patients treated with CRT-D.
    Kutyifa V; Klein HU; Wang PJ; McNitt S; Polonsky B; Zima E; Merkely B; Moss AJ; Zareba W
    Heart Rhythm; 2013 Jul; 10(7):943-50. PubMed ID: 23639624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy.
    Levine YC; Matos J; Rosenberg MA; Manning WJ; Josephson ME; Buxton AE
    Heart Rhythm; 2016 Feb; 13(2):490-7. PubMed ID: 26409099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcome in patients with severe left ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias.
    Pelicano N; Oliveira M; Da Silva N; Antunes E; Santos S; Conceição JM; Roquette J; Quininha J
    Rev Port Cardiol; 2005 Apr; 24(4):487-98. PubMed ID: 15977773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of nonsustained ventricular tachycardia morphology in high-risk patients with hypertrophic cardiomyopathy.
    Adduci C; Boldini F; Palano F; Musumeci B; De Lucia C; Russo D; Volpe M; Autore C; Francia P
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2093-2098. PubMed ID: 32437006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of rapid-rate non-sustained ventricular tachycardia in the occurrence of appropriate implantable cardioverter-defibrillator therapy.
    Zhou Y; Zhao S; Chen K; Hua W; Su Y; Chen S; Liang Z; Xu W; Zhang S
    J Interv Card Electrophysiol; 2020 Apr; 57(3):473-480. PubMed ID: 31073687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
    Chen J; Johnson G; Hellkamp AS; Anderson J; Mark DB; Lee KL; Bardy GH; Poole JE
    J Am Coll Cardiol; 2013 May; 61(21):2161-8. PubMed ID: 23541974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?
    Koyak Z; de Groot JR; Van Gelder IC; Bouma BJ; van Dessel PF; Budts W; van Erven L; van Dijk AP; Wilde AA; Pieper PG; Sieswerda GT; Mulder BJ
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):101-10. PubMed ID: 22095638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very high rate programming in primary prevention patients with reduced ejection fraction implanted with a defibrillator: Results from a large multicenter controlled study.
    Clementy N; Challal F; Marijon E; Boveda S; Defaye P; Leclercq C; Deharo JC; Sadoul N; Klug D; Piot O; Gras D; Bordachar P; Algalarrondo V; Fauchier L; Babuty D;
    Heart Rhythm; 2017 Feb; 14(2):211-217. PubMed ID: 27989789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified?
    Russo AM; Nayak H; Verdino R; Springman J; Gerstenfeld E; Hsia H; Marchlinski FE
    Pacing Clin Electrophysiol; 2003 Dec; 26(12):2289-95. PubMed ID: 14675014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention.
    Lee WC; Chen HC; Chen YL; Tsai TH; Pan KL; Lin YS; Chen MC
    BMC Cardiovasc Disord; 2016 Nov; 16(1):231. PubMed ID: 27871248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of CMR in patients presenting with ventricular arrhythmias.
    Dawson DK; Hawlisch K; Prescott G; Roussin I; Di Pietro E; Deac M; Wong J; Frenneaux MP; Pennell DJ; Prasad SK
    JACC Cardiovasc Imaging; 2013 Mar; 6(3):335-44. PubMed ID: 23433931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyssynchrony and the risk of ventricular arrhythmias.
    Kutyifa V; Pouleur AC; Knappe D; Al-Ahmad A; Gibinski M; Wang PJ; McNitt S; Merkely B; Goldenberg I; Solomon SD; Moss AJ; Zareba W
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):432-44. PubMed ID: 23579010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of nonsustained and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
    Zhou X; Gunderson BD; Olson WH;
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):14-20. PubMed ID: 15028067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.